Par Drugs and Chemicals Limited (PAR.NS)
INR 103.99
(4.61%)
INR 103.99
(4.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 145.01 Million INR | 27.94% |
| 2022 | 113.34 Million INR | 23.02% |
| 2021 | 92.13 Million INR | -20.65% |
| 2020 | 116.11 Million INR | 143.68% |
| 2019 | 47.64 Million INR | 97.0% |
| 2018 | 24.18 Million INR | 61.76% |
| 2017 | 14.95 Million INR | -19.08% |
| 2016 | 18.47 Million INR | 338.07% |
| 2015 | 4.21 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 25.33 Million INR | -31.89% |
| 2024 Q2 | 85.95 Million INR | 239.34% |
| 2023 Q2 | 48.91 Million INR | 98.25% |
| 2023 Q1 | 24.67 Million INR | -28.42% |
| 2023 Q3 | 34.22 Million INR | -30.04% |
| 2023 Q4 | 37.19 Million INR | 8.68% |
| 2023 FY | 145.01 Million INR | 27.94% |
| 2022 Q2 | 37.25 Million INR | 62.38% |
| 2022 Q4 | 34.47 Million INR | 84.53% |
| 2022 FY | 113.34 Million INR | 23.02% |
| 2022 Q1 | 22.94 Million INR | -5.37% |
| 2022 Q3 | 18.68 Million INR | -49.85% |
| 2021 Q1 | 24.55 Million INR | -44.42% |
| 2021 FY | 92.13 Million INR | -20.65% |
| 2021 Q4 | 24.24 Million INR | 14.6% |
| 2021 Q3 | 21.15 Million INR | -4.73% |
| 2021 Q2 | 22.2 Million INR | -9.57% |
| 2020 Q4 | 44.17 Million INR | 112.05% |
| 2020 Q3 | 20.83 Million INR | -18.48% |
| 2020 FY | 116.11 Million INR | 143.68% |
| 2020 Q1 | 25.55 Million INR | 60.9% |
| 2020 Q2 | 25.55 Million INR | 0.0% |
| 2019 Q4 | 15.88 Million INR | 0.0% |
| 2019 FY | 47.64 Million INR | 97.0% |
| 2019 Q3 | 15.88 Million INR | 99.95% |
| 2019 Q2 | 7.94 Million INR | 0.0% |
| 2019 Q1 | 7.94 Million INR | 280.37% |
| 2018 Q4 | 2.08 Million INR | 0.0% |
| 2018 FY | 24.18 Million INR | 61.76% |
| 2018 Q1 | 6.83 Million INR | 0.0% |
| 2018 Q2 | 6.83 Million INR | 0.0% |
| 2018 Q3 | 2.08 Million INR | -69.46% |
| 2017 FY | 14.95 Million INR | -19.08% |
| 2016 FY | 18.47 Million INR | 338.07% |
| 2015 FY | 4.21 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 449.72 Million INR | 67.756% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -1944.698% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 96.828% |
| FDC Limited | 3.05 Billion INR | 95.249% |
| Gufic Biosciences Limited | 861.35 Million INR | 83.165% |
| Hikal Limited | 696 Million INR | 79.165% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 96.555% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 89.213% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 0.688% |
| Medico Remedies Limited | 82.9 Million INR | -74.903% |
| Nectar Lifesciences Limited | 49.95 Million INR | -190.31% |
| RPG Life Sciences Limited | 876.6 Million INR | 83.458% |
| Sequent Scientific Limited | -358.69 Million INR | 140.428% |
| Shilpa Medicare Limited | 318.74 Million INR | 54.506% |
| Sigachi Industries Limited | 571.8 Million INR | 74.64% |
| Themis Medicare Limited | 435.23 Million INR | 66.683% |
| Unichem Laboratories Limited | -704.74 Million INR | 120.576% |
| Venus Remedies Limited | 284.9 Million INR | 49.103% |
| Wanbury Limited | 559.56 Million INR | 74.085% |
| ZIM Laboratories Limited | 172.46 Million INR | 15.919% |
| Lupin Limited | 19.14 Billion INR | 99.243% |
| Innova Captab Limited | 943.45 Million INR | 84.63% |
| Ind-Swift Limited | 142.31 Million INR | -1.895% |
| Bajaj HealthCare Limited | -837.93 Million INR | 117.306% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 99.543% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 102.556% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 91.022% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 259.849% |
| Morepen Laboratories Limited | 961.59 Million INR | 84.92% |
| Laurus Labs Limited | 1.6 Billion INR | 90.968% |
| Aarti Drugs Limited | 1.71 Billion INR | 91.541% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 96.92% |
| Alembic Limited | 2.68 Billion INR | 94.602% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 97.645% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.966% |
| Vaishali Pharma Limited | 7.18 Million INR | -1917.109% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 93.314% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 35.445% |
| Jubilant Pharmova Limited | 771 Million INR | 81.192% |
| Eris Lifesciences Limited | 3.91 Billion INR | 96.301% |
| Windlas Biotech Limited | 581.87 Million INR | 75.079% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.849% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 84.458% |
| Orchid Pharma Limited | 921.66 Million INR | 84.267% |
| Albert David Limited | 754.2 Million INR | 80.773% |
| Hester Biosciences Limited | 188.89 Million INR | 23.23% |
| Sakar Healthcare Limited | 116.7 Million INR | -24.249% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 95.171% |
| Procter & Gamble Health Limited | 2 Billion INR | 92.785% |
| Divi's Laboratories Limited | 16 Billion INR | 99.094% |
| Mankind Pharma Limited | 19.12 Billion INR | 99.242% |
| Neuland Laboratories Limited | 3 Billion INR | 95.168% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 97.376% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 99.624% |
| Wockhardt Limited | -4.63 Billion INR | 103.132% |
| Bal Pharma Limited | 73.92 Million INR | -96.166% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.74% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 80.782% |
| Alkem Laboratories Limited | 17.95 Billion INR | 99.192% |
| Valiant Laboratories Limited | 3.19 Million INR | -4437.234% |
| Ajanta Pharma Limited | 8.16 Billion INR | 98.223% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -97.349% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -209.608% |
| Granules India Limited | 4.05 Billion INR | 96.422% |
| Medicamen Biotech Limited | 109.31 Million INR | -32.659% |
| Ipca Laboratories Limited | 5.47 Billion INR | 97.351% |
| Brooks Laboratories Limited | -195.91 Million INR | 174.015% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 42.716% |
| Piramal Enterprises Limited | -16.83 Billion INR | 100.861% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.125% |
| NATCO Pharma Limited | 13.88 Billion INR | 98.955% |
| Suven Life Sciences Limited | -1.05 Billion INR | 113.8% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 173.503% |
| Strides Pharma Science Limited | -706.14 Million INR | 120.536% |
| Indoco Remedies Limited | 984.6 Million INR | 85.272% |
| Alpa Laboratories Limited | 167.76 Million INR | 13.564% |
| Lasa Supergenerics Limited | -217.3 Million INR | 166.731% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 103.745% |